Last reviewed · How we verify
AK159
At a glance
| Generic name | AK159 |
|---|---|
| Sponsor | Asahi Kasei Pharma Corporation |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Phase I Study of AK159 in Healthy Postmenopausal Women (PHASE1)
- Clinical Study of AK159 in Healthy Postmenopausal Women (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- AK159 CI brief — competitive landscape report
- AK159 updates RSS · CI watch RSS
- Asahi Kasei Pharma Corporation portfolio CI